146 related articles for article (PubMed ID: 12519589)
1. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Miller R; Barnes P
Cochrane Database Syst Rev; 2002; (4):CD003218. PubMed ID: 12519589
[TBL] [Abstract][Full Text] [Related]
2. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Moore DH; Barnes PR; Miller RG
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003218. PubMed ID: 16855999
[TBL] [Abstract][Full Text] [Related]
3. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
4. Selegiline in the treatment of hypersomnolence in myotonic dystrophy: a pilot study.
Antonini G; Morino S; Fiorelli M; Fiorini M; Giubilei F
J Neurol Sci; 1997 Apr; 147(2):167-9. PubMed ID: 9106123
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
Puymirat J; Bouchard JP; Mathieu J
Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
[TBL] [Abstract][Full Text] [Related]
6. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
7. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Talbot K; Stradling J; Crosby J; Hilton-Jones D
Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
Dauvilliers YA; Laberge L
Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment for myotonia.
Trip J; Drost G; van Engelen BG; Faber CG
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004762. PubMed ID: 16437496
[TBL] [Abstract][Full Text] [Related]
10. [Excessive daytime sleepiness, central type sleep apnea and myotonic dystrophy].
Reimão R; Lemmi H; Bertorini T
Arq Neuropsiquiatr; 1985 Dec; 43(4):391-5. PubMed ID: 3833140
[TBL] [Abstract][Full Text] [Related]
11. Strength training and aerobic exercise training for muscle disease.
van der Kooi EL; Lindeman E; Riphagen I
Cochrane Database Syst Rev; 2005 Jan; (1):CD003907. PubMed ID: 15674918
[TBL] [Abstract][Full Text] [Related]
12. Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.
Sansone VA; Proserpio P; Mauro L; Biostat AL; Frezza E; Lanza A; Rogliani P; Pezzuto G; Falcier E; Aggradi CF; Pirola A; Rao F; Roma E; Galluzzi C; Spanetta M; Cattaneo F; Rubino A; Agostoni EC; Amico F; Zanolini A; Izzi F; Greco G; Romigi A; Liguori C; Nobili L; Placidi F; Massa R
J Clin Sleep Med; 2021 Dec; 17(12):2383-2391. PubMed ID: 34170223
[TBL] [Abstract][Full Text] [Related]
13. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.
Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594
[TBL] [Abstract][Full Text] [Related]
14. Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.
Coccagna G; Mantovani M; Parchi C; Mironi F; Lugaresi E
J Neurol Neurosurg Psychiatry; 1975 Oct; 38(10):977-84. PubMed ID: 172608
[TBL] [Abstract][Full Text] [Related]
15. Apathy and hypersomnia are common features of myotonic dystrophy.
Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
[TBL] [Abstract][Full Text] [Related]
16. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2000; (2):CD000442. PubMed ID: 10796544
[TBL] [Abstract][Full Text] [Related]
17. Does abnormal neuronal excitability exist in myotonic dystrophy? II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia.
Di Costanzo A; Mottola A; Toriello A; Di Iorio G; Tedeschi G; Bonavita V
Neurol Sci; 2000 Apr; 21(2):81-6. PubMed ID: 10938185
[TBL] [Abstract][Full Text] [Related]
18. Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy with alveolar hypoventilation and hypersomnia: a clinicopathological study.
Ono S; Kurisaki H; Sakuma A; Nagao K
J Neurol Sci; 1995 Feb; 128(2):225-31. PubMed ID: 7738599
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of Daytime Sleepiness and Fatigue Scales in Myotonic Dystrophy Type 1.
Laberge L; Gallais B; Auclair J; Dauvilliers Y; Côté I; Mathieu J; Gagnon C
Can J Neurol Sci; 2022 Mar; 49(2):287-290. PubMed ID: 33875033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
